Neonatal Life-Threatening Nonoliguric Hyperkalemia Under Therapeutic Hypothermia.


Journal

Therapeutic hypothermia and temperature management
ISSN: 2153-7933
Titre abrégé: Ther Hypothermia Temp Manag
Pays: United States
ID NLM: 101543518

Informations de publication

Date de publication:
Dec 2021
Historique:
pubmed: 8 10 2021
medline: 15 12 2021
entrez: 7 10 2021
Statut: ppublish

Résumé

To illustrate our experience with two cases of neonatal life-threatening hyperkalemia during therapeutic hypothermia (TH) despite a normal acid-base status, urine output, and preserved renal function. Clinical cases are presented from Pediatric Intensive Care Unit (PICU) admission to the onset of the hyperkalemia, with related complications and after resolution. Similar cases were not retrieved from a critical review of pertinent literature. Severe hyperkalemia pathophysiology and risk factors have been debated. Two full-term adequate for weight female neonates were admitted to PICU because of perinatal asphyxia who underwent TH. Prenatal history was completely uneventful, nor hereditary genetic conditions were reported; moreover, long-term follow-up ruled out any metabolic or renal disease. Despite an accurate evaluation of previous clinical series and literature on TH and perinatal asphyxia, these hyperkalemic episodes remain unexplained. The hypoxic-ischemic insult may affect multiple organs, mainly central nervous system, heart, lung, and kidneys; acute muscle breakdown and consequent rising of myoglobin may also have a precipitating role in acute kidney failure (AKF) and hyperkalemia. Electrolyte imbalance is a possible finding as a consequence of combined cell injury and AKF. In contrast, an isolated severe hyperkalemia is exceedingly rare in nonoliguric neonates.

Identifiants

pubmed: 34619071
doi: 10.1089/ther.2021.0009
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

238-241

Auteurs

Marco Piastra (M)

Pediatric ICU and Trauma Center, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.
Institute of Anesthesia and Intensive Care, Catholic University of the Sacred Heart of Rome, Rome, Italy.

Alessia Tempera (A)

Neonatal Intensive Care Unit, Maternal-Fetal Department, S. Camillo-Forlanini Hospital, Rome, Italy.

Maria Pia De Carolis (MP)

Department of Woman and Child Health and Public Health, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.

Lucilla Pezza (L)

Pediatric ICU and Trauma Center, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.
Department of Woman and Child Health and Public Health, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.

Orazio Genovese (O)

Pediatric ICU and Trauma Center, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.

Cristina Benassi (C)

Pediatric ICU and Trauma Center, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.

Tony C Morena (TC)

Pediatric ICU and Trauma Center, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.

Enzo Picconi (E)

Pediatric ICU and Trauma Center, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.

Geremia Zito (G)

ICU Santobono Pediatic Hospital, Naples, Italy.

Gabriella De Rosa (G)

Department of Woman and Child Health and Public Health, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.

Giorgio Conti (G)

Pediatric ICU and Trauma Center, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.
Institute of Anesthesia and Intensive Care, Catholic University of the Sacred Heart of Rome, Rome, Italy.

Daniele De Luca (D)

Division of Pediatrics and Neonatal Critical Care, Centre Antoine Beclere, Paris-Saclay University Hospitals APHP, Paris, Ile-de France, France.
Physiopathology and Therapeutic Innovation Unit INSERUM U999 Paris, Université Paris-Saclay APHP, Ile-de France, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH